Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats

Psychopharmacology

Volumn 213, Issue 2-3, 2011, Pages 365-376

  Rodsiri, Ratchanee ^a   Spicer, Clare ^a   Green, A Richard ^a   Marsden, Charles A ^a   Fone, Kevin C F ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

3,4 methylenedioxymethamphetamine; 5 HT; Body temperature; In vivo microdialysis; Locomotor activity; Novel object discrimination; Radiotelemetry

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DRUG EXPOSURE; EXTRACELLULAR MATRIX; HIPPOCAMPUS; HYPERACTIVITY; HYPERTHERMIA; HYPOTHERMIA; MALE; MEMORY DISORDER; NERVE CELL; NEUROTOXICITY; NONHUMAN; PERCEPTION DISORDER; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SEROTONIN RELEASE;

ANIMALS; BODY TEMPERATURE; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEVER; HIPPOCAMPUS; LOCOMOTION; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; SEROTONIN; SEROTONIN AGENTS; TELEMETRY;

EID: 79952486766     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1921-9     Document Type: Article

References (57)

1. Able JA, Gudelsky GA, Vorhees CV, Williams MT (2006) 3, 4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatry 59:1219-1226
2. Bankson MG, Cunningham KA (2002) Pharmacological studies of the acute effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. Neuropsychopharmacology 26:40-52 (Pubitemid 34075275)
3. Baumann MH, Clark RD, Franken FH, Rutter JJ, Rothman RB (2008a) Tolerance to 3, 4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience 152:773-784
4. Baumann MH, Clark RD, Rothman RB (2008b) Locomotor stimulation produced by 3, 4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol Biochem Behav 90:208-217
5. Benamar K, Geller EB, Adler MW (2008) A new brain area affected by 3, 4-methylenedioxymethamphetamine: a microdialysisbiotelemetry study. Eur J Pharmacol 596:84-88
6. Bianchi M, Fone KCF, Azmi N, Heidbreder CA, Hagan JJ, Marsden CA (2006) Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. Eur J Neurosci 24:2894-2902 (Pubitemid 44813840)
7. Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV (2001) 3, 4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci 21:3228-3235 (Pubitemid 32323504)
8. Bull EJ, Hutson PH, Fone KCF (2004) Decreased social behaviour following 3, 4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity. Neuropharmacology 46:202-210 (Pubitemid 37532828)
9. Bull EJ, Porkess V, Rigby M, Hutson PH, Fone KC (2006) Pre-treatment with 3, 4-methylenedioxymethamphetamine (MDMA) causes longlasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain. J Psychopharmacol 20:272-280
10. Callaway CW, Wing LL, Geyer MA (1990) Serotonin release contributes to the locomotorstimulant effects of 3, 4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254:456-464 (Pubitemid 20262081)
11. Capela JP, Carmo H, Remiao F, Bastos ML, Meisel A, Carvalho F (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39:210-271
12. Chance M (1947) Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice. J Pharmacol Exp Ther 87:214-219
13. Che S, Johnson M, Hanson GR, Gibb JW(1995) Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity. Eur J Pharmacol 293:447-453
14. Dafters RI (1994) Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3, 4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Psychopharmacology 114:505-508
15. Dafters RI (1995) Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol Behav 58:877-882
16. Docherty JD, Green AR (2010). The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and derivatives. Br J Pharmacol (in press).
17. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31:47-59
18. Esteban B, O'shea E, Camarero J, Sanchez V, Green AR, Colado MI (2001) 3, 4-methylenedioxymethamphetamine induces monoamine release but not toxicity when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154:251-260
19. Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC et al (2003) Pharmacological characterization of the effects of 3, 4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology 166:202-211 (Pubitemid 36384765)
20. Fone KCF, Beckett SR, Topham IA, Swettenham J, Ball M, Maddocks L (2002) Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology 159:437-444 (Pubitemid 34143369)
21. Freedman RR, Johanson CE, Tancer ME (2005) Thermoregulatory effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 183:248-256 (Pubitemid 41609277)
22. Goñi-Allo B, Mathúna BÓ, Segura M, Puerta E, Lasheras B, de la Torre R, Aguirre N (2008) The relationship between core body temperature and 3, 4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity. Psychopharmacology 197:263-278
23. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ et al (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719-725 (Pubitemid 30265271)
24. Green AR, Mechan AO, Elliott JM, O'shea E, Colado MI (2003) The pharmacology and cl inical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508
25. Green AR, Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI (2004) Effect of ambient temperature and a prior neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. Psychopharmacology 173:264-269 (Pubitemid 38703799)
26. Green AR, O'shea E, Saadat KS, Elliott JM, Colado MI (2005) Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures. Br J Pharmacol 146:306-312
27. Green AR, Gabrielsson J, Marsden CA, Fone KCF (2009) MDMA: On the translation from rodent to human dosing. Psychopharmacology 204:375-378
28. Hammersley R, Ditton J, Smith I, Short E (1999) Patterns of ecstasy use by drug users. Br J Criminol 39:625-647
29. Irvine RJ, Keane M, Felgate P, McCann UD, Callaghan PD, White JM (2006) Plasma drug concentrations and physiological measures in 'dance party' participants. Neuropsychopharmacology 31:424-430
30. Johnson M, Mitros K, Stone DM, Zobrist R, Hanson GR, Gibb JW (1992) Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3, 4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 261:586-591
31. Kindlundh-Hogberg AM, Schioth HB, Svenningsson P (2007) Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain. Neurotoxicology 28:1158-1169 (Pubitemid 350026594)
32. King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KCF (2004) 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation - an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47:195-204 (Pubitemid 38824643)
33. King MV, Spicer C, Sleight AJ, Marsden CA, Fone KCF (2009) Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task. Psychopharmacology 202:111-123
34. Malberg JE, Seiden LS (1998) Small changes in ambient temperature cause large changes in 3, 4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18:5086-5094 (Pubitemid 28285417)
35. Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP (1999) Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology 144:67-76 (Pubitemid 29242672)
36. McGregor IS, Gurtman CG, Morley KC, Clemens KJ, Blokland A, Li KM et al (2003) Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology 168:465-474 (Pubitemid 36994030)
37. Mechan AO, Esteban B, O'shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3, 4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135:170-180
38. Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS (2001) Increased anxiety and impaired memory in rats 3 months after administration of 3, 4-methylenedioxymethamphetamine ("ecstasy"). Eur J Pharmacol 433:91-99 (Pubitemid 34038085)
39. Morton AJ, Hickey MA, Dean LC (2001) Methamphetamine toxicity in mice is potentiated by exposure to loud music. NeuroReport 12:3277-3281 (Pubitemid 33010656)
40. O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37:919-926 (Pubitemid 28375758)
41. O'Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR et al (2005) Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology 30:1312-1323 (Pubitemid 40848085)
42. O'Shea E, Orio L, Escobedo I, Sanchez V, Camarero J, Green AR et al (2006) MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature. Br J Pharmacol 148:778-785 (Pubitemid 44079407)
43. Parrott AC (2005) Chronic tolerance to recreational MDMA (3, 4-methylenedioxymethamphetamine) or Ecstasy. J Psychopharmacol 19:71-83
44. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edition, 4th edn. Academic, London
45. Piper BJ, Meyer JS (2004) Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period. Pharmacol Biochem Behav 79:723-731 (Pubitemid 39600612)
46. Skelton MR, Able JA, Grace CE, Herring NR, Schaefer TL, Gudelsky GA et al (2008) (+/-)-3, 4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks. Neuropharmacology 55:1121-1130
47. Sprague JE, Preston AS, Leifheit M, Woodside B (2003) Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol Behav 79:281-287 (Pubitemid 36780968)
48. Stanley N, Salem A, Irvine RJ (2007) The effects of co-administration of 3, 4-methylenedioxymethamphetamine ("ecstasy") or paramethoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats. Neuroscience 146:321-329 (Pubitemid 46654614)
49. Starr MA, Page ME, Waterhouse BD (2008) MDMA (3,4 methylene- dioxymethamphetamine)-mediated distortion of somatosensory signal transmission and neurotransmitter efflux in the ventral posteriormedial thalamus. J Pharmacol Exp Ther 327:20-31
50. Stone DM, Merchant KM, Hanson GR, Gibb JW (1987) Immediate and long-term effects of 3, 4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 26:1677-1683 (Pubitemid 18007648)
51. Topp L, Hando J, Dillon P, Roche A, Solowij N (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55:105-115 (Pubitemid 29222009)
52. Tucker GT, Lennard MS, Ellis SW, Woods HF, Cho AK, Lin LY et al (1994) The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol 47:1151-1156
53. Von Huben SN, Lay CC, Crean RD, Davis SA, Katner SN, Taffe MA (2007) Impact of ambient temperature on hyperthermia induced by (+/-)3, 4-methylenedioxymethamphetamine in rhesus macaques. Neuropsychopharmacology 32:673-681
54. Winstock AR, Griffiths P, Stewart D (2001) Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 64:9-17 (Pubitemid 32695429)
55. Yang JS, Jamei M, Heydari A, Yeo KR, de la Torre R, Farre M et al (2006) Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA. J Psychopharmacol 20:842-849 (Pubitemid 44622750)
56. Yehuda S, Wurtman RJ (1972a) Effects of d-amphetamine and related drugs on colonic temperatures of rats kept at various ambient temperatures. Life Sci Physiol Pharmacol 11:851-859
57. Yehuda S, Wurtman RJ (1972b) Release of brain dopamine as probable mechanism for hypothermic effect of d-amphetamine. Nature 240:477-478